Xencor, Inc.
ICOS TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND ICOS ANTIGEN BINDING DOMAINS
Last updated:
Abstract:
The present invention is directed to novel targeted heterodimeric Fc fusion proteins comprising an IL-15/IL-15R.alpha. Fc-fusion protein and a ICOS antibody fragment-Fc fusion protein.
Status:
Application
Type:
Utility
Filling date:
23 Dec 2021
Issue date:
21 Jul 2022